Appendix 1A — ASX Listing Application and Agreement is required by listing rule 1.7 to be used by an entity seeking admission to the official list as an ASX Listing.
View Appendix 1A — ASX Listing Application and Agreement.
Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer
February 19, 2025
MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce